September 16, 2014 — Advanced Accelerator Applications (AAA), an international specialist in molecular nuclear medicine, announced this week it has entered into an agreement with GE Healthcare in Italy to acquire its Italian FDG-PET imaging agent business (fluorodeoxyglucose positron emission tomography). This acquisition includes the license to market GE Healthcare’s SteriPET (FDG) imaging agent in Italy.

Stefano Buono, CEO of AAA, said: “This acquisition is in line with AAA’s growth strategy of further consolidating our position as a leading pan-European nuclear diagnostics company, alongside exploring additional product pipeline opportunities and avenues for expansion in the United States and outside Europe.”

“We believe that this transaction will enable AAA Italy to benefit from economies of scale from which we can continue providing quality products and services at reduced costs in a market that has been experiencing a reduction of FDG’s price over the last years,” added Enrico De Maria, CEO of AAA Italy.

AAA’s diagnostic PET product is Gluscan, its branded FDG PET imaging agent. Gluscan assists in the diagnosis of serious diseases, primarily in oncology, by assessing glucose metabolism. The company has 13 PET production facilities based in France, Germany, Italy, Poland, Portugal and Spain. With this acquisition AAA intends to broaden its presence in the Italian PET market and add to its existing production capacity and portfolio.

For more information: www.adacap.com

Related Content

News | Radiopharmaceuticals and Tracers

September 17, 2021 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and ...

Time September 17, 2021
arrow
News | Radiopharmaceuticals and Tracers

September 10, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time September 10, 2021
arrow
News | Nuclear Imaging

June 22, 2021 — At the Society of Nuclear Medicine and Molecular Imaging’s (SNMMI) 2021 summer conference, GE Healthcare ...

Time June 22, 2021
arrow
News | Radiopharmaceuticals and Tracers

June 22, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time June 22, 2021
arrow
News | Radiopharmaceuticals and Tracers

April 16, 2021 — NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and ...

Time April 16, 2021
arrow
News | Radiopharmaceuticals and Tracers

March 26, 2021 — Shine Medical Technologies LLC announced that construction of the exterior structure of its first-of-a ...

Time March 26, 2021
arrow
News | Nuclear Imaging

March 8, 2021 — IBA (Ion Beam Applications S.A., EURONEXT) and NorthStar Medical Radioisotopes, LLC, announced a ...

Time March 08, 2021
arrow
News | PET Imaging

January 29, 2021 — Fuzionaire Radioisotope Technologies K.K. (“FRIT”) announced that it has entered into a feasibility ...

Time January 29, 2021
arrow
News | Radiopharmaceuticals and Tracers

February 18, 2020 — NorthStar Medical Radioisotopes, LLC, a global innovator in the production and distribution of ...

Time February 18, 2020
arrow
News | Nuclear Imaging

December 26, 2019 — The Feinstein Institutes for Medical Research has received U.S. Food and Drug Administration (FDA) ...

Time December 26, 2019
arrow
Subscribe Now